Decreased expression of α-catenin is associated with poor prognosis of patients with localized renal cell carcinoma

International Journal of Cancer

Volumn 74, Issue 5, 1997, Pages 523-528

  Shimazui, Tom ^a,b   Bringuier, Pierre Paul ^a   Van Berkel, Hans ^a   Ruijter, Emiel ^a   Akaza, Hideyuki ^b   Debruyne, Frans M J ^a   Oosterwijk, Egbert ^a   Schalken, Jack A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CATENIN; BETA CATENIN; CATENIN; CELL ADHESION MOLECULE; PROTEIN P 120 CAS; UNCLASSIFIED DRUG; UVOMORULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA CATENIN; BLOTTING, WESTERN; CADHERINS; CARCINOMA, RENAL CELL; CELL ADHESION; CELL ADHESION MOLECULES; CYTOSKELETAL PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MIDDLE AGED; PHOSPHOPROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 0030659078     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971021)74:5<523::AID-IJC8>3.0.CO;2-5     Document Type: Article

References (33)

1. BANDER, N.H., FINSTAD, C.L., CORDON-CARDO, C. RAMSAWAK, R.D., VAUGHAN, JR., E.D., WHITMORE, JR., W.F., OETTGEN, H.F., MELAMED, M.R. and OLD, L.J., Analysis of a mouse monoclonal antibody that reacts with a specific region of the human proximal tubule and subsets renal cell carcinomas. Cancer Res., 49, 6774-6780 (1984).
2. BOT, F.J., GODSCHALK, J.C., KRISHNADATH, K.K., VAN PER KWAST, T.H. and BOSMAN, F.J., Prognostic factors in renal cell carcinoma: immunohistochemical detection of p53 protein versus clinico-pathological parameters. Int. J. Cancer 57, 634-637 (1994).
3. CHAUHAN, S.S., GOLDSTEIN, L.J. and GOTTESMAN, M.M., Expression of cathepsin L in human tumors. Cancer Res., 51, 1478-1481 (1991).
4. DANIEL, J.M. and REYNOLDS, A.B., The tyrosine kinase substrate p120cas binds directly to E-cadherin but not to the adenomatous polyposis coli protein of α-catenin. Mol. cell. Biol., 15, 4819-4824 (1995).
5. DELAHUNT, B., RIBAS, J.L., NACEY, J.N. and BETHWAITE, P.B., Nucleolar organizer regions and prognosis in renal cell carcinoma. J. Pathol., 163, 31-37 (1991).
6. DE RIESE, W.T.W., CRABTREE, W.N., ALLHOFF, E.P., WERNER, M., LIEDKE, S., LENIS, G., ATZPODIEN, J. and KIRCHNER, H., Prognostic significance of Ki-67 immunostaining in nonmetastatic renal cell carcinoma. J. clin. Oncol., 11, 1804-1808 (1993).
7. FLINT, A., GROSSMAN, H.B., LIEBERT, M., LLOYD, R.V. and BROMBERG, J., DNA and PCNA content of renal cell carcinoma and prognosis. Amer. J. clin. Pathol., 103, 14-19 (1995).
8. FOSTER, K., CROSSEY, P.A., CAIRNS, P., HETHERINGTON, J.W., RICHARDS, F.M., JONES, M.H., BENTLEY, E., AFFARA, N.A., FERGUSON-SMITH, M.A. and MAHER, E.R., Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22. Brit. J. Cancer, 69, 230-234 (1994).
9. GIROLDI, L.A., BRINGUIER, P.P. and SCHALKEN, J.A., Defective E-cadherin function in urological cancers: clinical implications and molecular mechanisms. Invasion Metastasis, 14, 71-81 (1995).
10. HOLTHOFER, H., MIETTINEN, A., PAASIVUO, R., LEHTO, V.-P., UNDER, E., ALFTHAN, O. and VIRTANEN, I., Cellular origin and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins. Lab. Invest., 49, 317-326 (1983).
11. INTERNATIONAL UNION AGAINST CANCER TNM classification (kidney cancer). In: P. Hermanek and L-H. Sobin (eds.), TNM classification of malignant tumors (4th ed.), pp. 136-138, Springer-Verlag, Berlin (1992).
12. KATAGIRI, A., WATANABE, R. and TOMITA, Y., E-cadherin expression in renal cell cancer and its significance in metastasis and survival. Brit. J. Cancer, 71, 376-379 (1995).
13. KOVACS, G., The value of molecular genetic analysis in the diagnosis and prognosis of renal cell tumors. World J. Urol., 12, 64-68 (1994).
14. LJUNGBERG, B., FORSSLUND, G., STENLING, R. and ROOS, G., Prognostic significance of the DNA content in renal cell carcinoma. J. Urol., 135, 422-426 (1986).
15. McNICHOLS, D.W., SEGURA, J.W. and DEWEERD, J.H., Renal cell carcinoma: long-term survival and late recurrence. J. Urol., 126, 17-23 (1981).
16. MO, Y.-Y. and REYNOLDS, A.B., Identification of murine p120cas isoforms and heterogeneous expression of p120cas isoforms in human tumor cells. Cancer Res., 56, 2633-2640 (1996).
17. MOSTOFI, F.K., Histological typing of kidney tumours. In: International histological classical of tumours (25). World Health Organization, Geneva (1982).
18. MURPHY, G.F., PARTIN, A.W., MAYGARDEN, S.J. and MOHLER, J.L., Nuclear shape analysis for assessment of prognosis in renal cell carcinoma. J. Urol., 143, 1103-1107 (1990).
19. MURPHY, W.M., Disease of the kidney. In: Urological pathology, pp. 409-482, W.B. Saunders, Philadelphia (1989).
20. NANUS, D.M., MENTLE, I.R., MOTZER, R.J., BANDER, N.H. and ALBINO, A.P., Infrequent ras oncogene point mutation in renal cell carcinoma. J. Urol., 143, 175-178 (1990).
21. NOUWEN, E.J., DAUWE, S., VAN DER BIEST, I. and DE BROE, M.E., Stage- and segment-specific expression of cell-adhesion molecules N-CAM, A-CAM, and L-CAM in the kidney. Kidney Int., 44, 147-158 (1993).
22. ODA, H., NAKATSURU, Y. and ISHIKAWA, T., Mutation of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinoma. Cancer Res., 55, 658-662 (1995).
23. OOSTERWIJK, E., RUITER, J., WAKKA, J.C., VAN DER MEIJ, H., JONAS, U., FLEUREN, G.J., ZWARTENDIJK, J., HOEDEMAEKER, P.H. and WARNAAR, S.O., Immunohistochemical analysis of monoclonal antibodies to renal antigen application in the diagnosis of renal cell carcinoma. Amer. J. Pathol., 123, 301-309 (1986).
24. OOSTERWIJK, E., WARNAAR, S.O., ZWARTENDIJK, J., VAN DER VELDE, E.A., FLEUREN, G.J. and CORNELISSE, C.J., Relationship between DNA ploidy, antigen expression and survival in renal cell carcinoma. Int. J. Cancer, 42, 703-708 (1988).
25. PAPADOPOULOS, I., WEICHERT JACOBSEN, K., SPRENGER, E. and WACKER, H.H., DNA content and the proliferation marker Ki-67 as prognostic indicator in renal cell carcinoma. Urol. Int., 53, 181-185 (1994).
26. PATEL, N.P. and LIVENGOOD, R.W., Renal cell cancer: natural history and results of treatment. J. Urol., 119, 722-726 (1977).
27. RIMM, D.L., SINARD, J.H. and MORROW, J.S., Reduced α-catenin and E-cadherin expression in breast cancer. Lab. Invest., 72, 491-493 (1995).
28. SHIMAZUI, T., GIROLDI, L., BRINGUIER, P.P., OOSTERWIJK, E. and SCHALKEN, J.A., Complex cadherin expression in renal cell carcinoma. Cancer Res., 56, 3234-3237 (1996).
29. SHIMAZUI, T., TOMOBE, M., HATTORI, K., UCHIDA, K., AKAZA, H. and KOISO, K., A prognostic significance of nucleolar organizer region (AgNOR) in renal cell carcinoma. J. Urol., 154, 1522-1526 (1995).
30. SHINOURA, N. and 12 OTHERS, Expression of N-cadherin and α-catenin in astrocytomas and glioblastomas. Brit. J. Cancer, 72, 627-633 (1995).
31. SKINNER, D.O., COLVIN, R.B., VERMILLION, C.D., PFISTER, R.C. and LEADBETTER, W.F., Diagnosis and management of renal cell carcinoma. A clinical and pathological study of 309 cases. Cancer, 28, 1165-1173 (1971).
32. TANI, T., LAITINEN, L., KANGAS, L., LEHTO, V.-P. and VIRTANEN, I., Expression of E- and N-cadherin in renal cell carcinomas, in renal cell carcinoma cell lines in vitro and in their xenografts. Int. J. Cancer, 64, 407-414 (1995).
33. VAN DER POEL, H.G., MULDERS, P.F.A., OOSTERHOF, G.O.N., SCHAAFSMA, H.E., HENDRIKS, J.C.M., SCHALKEN, J.A. and DEBRUYNE, F.M.J., Prognostic value of karyometric and clinical characteristics in renal cell carcinoma: quantitative assessment of tumor heterogeneity. Cancer, 72, 2667-2674 (1993).